2nd Quarter - Amendment

OURARING INC. for OURARING INC.

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to tax benefits for health technology.

LobbyistCovered position, as disclosed
WALTER KUHN New Chief Counsel, Senate Judiciary Committee, Senator Lindsey Graham (2007-2012)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to regulation of health technology. Issues related to insurance coverage of health technology.

LobbyistCovered position, as disclosed
WALTER KUHN New Chief Counsel, Senate Judiciary Committee, Senator Lindsey Graham (2007-2012)

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Copyright/Patent/Trademark CPT

Issues related to enforcement of intellectual property rights.

LobbyistCovered position, as disclosed
WALTER KUHN New Chief Counsel, Senate Judiciary Committee, Senator Lindsey Graham (2007-2012)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

Issues related to human performance technology; FY26 NDAA and FY26 Appropriations Act.

LobbyistCovered position, as disclosed
WALTER KUHN New Chief Counsel, Senate Judiciary Committee, Senator Lindsey Graham (2007-2012)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
OURA HEALTH LTD. Finland Finland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.